1. Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study;Böhme;Pain Clinic,2003
2. Buprenorphine the Unique Opioid Analgesic;Budd,2005
3. Grupo de Studio de Opioides de la Socieda Española del Dolor: Buprenorphine TDS in the treatment of chronic nociceptive, neuropathic and cancer-related pain;Camba;J App Ther Res,2007
4. The use of transdermal buprenorphine in chronic cancer pain treatment (Polish);Ciałkowska-Rysz;Medycyna Paliatywna,2009
5. The animal pharmacology of buprenorphine, an oripavine analgesic agent;Cowan;Br J Pharmacol,1977